Labshake search
Citations for Leinco Technologies :
1 - 8 of 8 citations for Annexin V Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2024Quote: Cell viability and apoptosis were measured using Annexin V-FITC/propidium iodide (PI) assay kit (Leinco Technologies; Fenton, MO) per manufacturer’s protocol ...
-
bioRxiv - Microbiology 2023Quote: ... or 500 µg MP1-22E9 mAb anti-GM-CSF (Leinco Technologies, Inc.) on -1- and 0dpi (47) ...
-
bioRxiv - Microbiology 2023Quote: ... Fc receptors were blocked for 10 minutes with CD32/CD16 mAb (Leinco Technologies, Inc.). Cells were incubated with Zombie UV™ Fixable Viability Dye (BioLegend ...
-
bioRxiv - Microbiology 2023Quote: ... Mice were injected intraperitoneally (i.p.) with 500 µg of control mAb rat IgG2a (Leinco Technologies, Inc.) or 500 µg MP1-22E9 mAb anti-GM-CSF (Leinco Technologies ...
-
bioRxiv - Immunology 2023Quote: ... and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) at a 40ng/ml concentration for 6 hours ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant purified N-terminal domain (NTD) of the SARS-CoV-2 was obtained from Leinco Technologies Inc (Cat #S853 ...
-
bioRxiv - Immunology 2023Quote: ... allowed to sit for 3 hours and treated with recombinant mouse IL-4 (Leinco technologies, Inc. I-207) for 4 hr ...
-
bioRxiv - Cell Biology 2022Quote: ... Goat anti-rabbit HRP secondary antibody (Leinco Technologies, R115); Goat Anti-rabbit Alexa 555 (Invitrogen ...